Nova Minerals Limited

NVA

Nova Minerals Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Melbourne, Victoria. The firm is focused on advancing the Estelle Project, comprising 514 square kilometers (km2) of State of Alaska mining claims, which includes multiple mining complexes across a 35-kilometer-long mineralized corridor of over 20 advanced gold and antimony prospects, including two multi-million-ounce resources, and several drill ready antimony prospects. The 85%-owned project is located 150 kilometers northwest of Anchorage, Alaska, United States of America, in the prolific Tintina Gold Belt, a province which hosts a 220 million-ounce (Moz) documented gold endowment and some of the gold mines and discoveries, including Barrick's Donlin Creek Gold Project and Kinross Gold Corporation's Fort Knox Gold Mine. The firm has two primary gold deposits at Estelle: RPM High-Grade Gold in the South, and Korbel Bulk Tonnage Gold in the North.

Neurizon Therapeutics Limited

NUZ

Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-10-05. The firm is engaged in advancing treatments for neurodegenerative diseases. The firm is focused on developing its lead drug candidate, NUZ-001, for the treatment of Amyotrophic Lateral Sclerosis (ALS), which is the common form of motor neuron disease. ALS is a devastating neurodegenerative condition that primarily affects nerve cells that control voluntary muscles.